Impact of solriamfetol treatment on sleep quality in Chinese patients with OSA-EDS: results of a randomized controlled trial.

Front Med (Lausanne) · 2026 · PMC12958185 · PMID 41788715

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The absence of a clear trend suggests that solriamfetol may not significantly influence the typical progression through these stages in a clinically meaningful manner.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.